Literature DB >> 25447324

The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.

Matthew J Benskey1, Fredric P Manfredsson2, Keith J Lookingland3, John L Goudreau4.   

Abstract

Parkinson disease causes degeneration of nigrostriatal dopamine (DA) neurons, while tuberoinfundibular DA neurons remain unaffected. A similar pattern is observed following exposure to 1-methy-4-phenyl-1,2,3,6-tetrahydropyradine (MPTP). The mechanism of tuberoinfundibular neuronal recovery from MPTP is associated with up-regulation of parkin protein. Here we tested if parkin mediates tuberoinfundibular neuronal recovery from MPTP by knocking-down parkin in tuberoinfundibular neurons using recombinant adeno-associated virus (rAAV), expressing a short hairpin RNA (shRNA) directed toward parkin. Following knockdown, axon terminal DA and tyrosine hydroxylase (TH) concentrations were analyzed 24h post-MPTP administration. rAAV-shRNA-mediated knockdown of endogenous parkin rendered tuberoinfundibular neurons susceptible to MPTP induced terminal DA loss, but not TH loss, within 24h post-MPTP. To determine if the neuroprotective benefits of parkin up-regulation could be translated to nigrostriatal neurons, rAAV expressing human parkin was injected into the substantia nigra of mice and axon terminal DA and TH concentrations were analyzed 24h post-MPTP. Nigral parkin over-expression prevented loss of TH in the axon terminals and soma of nigrostriatal neurons, but had no effect on terminal DA loss within 24h post-MPTP. These data show that parkin is necessary for the recovery of terminal DA concentrations within tuberoinfundibular neurons following acute MPTP administration, and parkin can rescue MPTP-induced decreases in TH within nigrostriatal neurons.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MPTP; Nigrostriatal; Parkin; Parkinson's disease; Tuberoinfundibular

Mesh:

Substances:

Year:  2014        PMID: 25447324      PMCID: PMC4339631          DOI: 10.1016/j.neuro.2014.11.004

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  48 in total

1.  Identification and distribution of Parkin in rat brain.

Authors:  J M Horowitz; J Myers; M K Stachowiak; G Torres
Journal:  Neuroreport       Date:  1999-11-08       Impact factor: 1.837

2.  An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.

Authors:  Y Imai; M Soda; H Inoue; N Hattori; Y Mizuno; R Takahashi
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

3.  Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.

Authors:  Y Imai; M Soda; R Takahashi
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

4.  Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors.

Authors:  Sergei Zolotukhin; Mark Potter; Irene Zolotukhin; Yoshihisa Sakai; Scott Loiler; Thomas J Fraites; Vince A Chiodo; Tina Phillipsberg; Nicholas Muzyczka; William W Hauswirth; Terance R Flotte; Barry J Byrne; Richard O Snyder
Journal:  Methods       Date:  2002-10       Impact factor: 3.608

5.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

6.  Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.

Authors:  Leonard Petrucelli; Casey O'Farrell; Paul J Lockhart; Melisa Baptista; Kathryn Kehoe; Liselot Vink; Peter Choi; Benjamin Wolozin; Matthew Farrer; John Hardy; Mark R Cookson
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

7.  Peroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration.

Authors:  D M Kuhn; C W Aretha; T J Geddes
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

8.  Nitration and inactivation of tyrosine hydroxylase by peroxynitrite.

Authors:  B Blanchard-Fillion; J M Souza; T Friel; G C Jiang; K Vrana; V Sharov; L Barrón; C Schöneich; C Quijano; B Alvarez; R Radi; S Przedborski; G S Fernando; J Horwitz; H Ischiropoulos
Journal:  J Biol Chem       Date:  2001-10-05       Impact factor: 5.157

Review 9.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

10.  S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.

Authors:  Kenny K K Chung; Bobby Thomas; Xiaojie Li; Olga Pletnikova; Juan C Troncoso; Laura Marsh; Valina L Dawson; Ted M Dawson
Journal:  Science       Date:  2004-04-22       Impact factor: 47.728

View more
  4 in total

1.  Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Authors:  Nicolas Giguère; Consiglia Pacelli; Caroline Saumure; Marie-Josée Bourque; Diana Matheoud; Daniel Levesque; Ruth S Slack; David S Park; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

2.  FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure.

Authors:  Joseph R Patterson; Elizabeth J Kim; John L Goudreau; Keith J Lookingland
Journal:  Brain Res       Date:  2016-08-24       Impact factor: 3.252

3.  Parkin represses 6-hydroxydopamine-induced apoptosis via stabilizing scaffold protein p62 in PC12 cells.

Authors:  Xiao-ou Hou; Jian-min Si; Hai-gang Ren; Dong Chen; Hong-feng Wang; Zheng Ying; Qing-song Hu; Feng Gao; Guang-hui Wang
Journal:  Acta Pharmacol Sin       Date:  2015-09-14       Impact factor: 6.150

4.  Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity.

Authors:  Matthew J Benskey; Rhyomi C Sellnow; Ivette M Sandoval; Caryl E Sortwell; Jack W Lipton; Fredric P Manfredsson
Journal:  Front Mol Neurosci       Date:  2018-02-13       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.